IPSEN BIOPHARM LIMITED
Get an alert when IPSEN BIOPHARM LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-10-17 (in 5mo)
Last made up 2025-10-03
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£647M
-15.3% vs 2023
Employees
713
+1.7% vs 2023
Profit before tax
£253M
-25.7% vs 2023
Name history
Renamed 3 times since incorporation
- IPSEN BIOPHARM LIMITED 2001-11-21 → present
- SPEYWOOD GROUP LIMITED 1995-01-16 → 2001-11-21
- PORTON INTERNATIONAL PLC 1984-01-27 → 1995-01-16
- ALARBROOK LIMITED 1982-07-23 → 1984-01-27
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £661,765,000 | £660,832,000 | |
| Operating profit | £322,346,000 | £237,706,000 | |
| Profit before tax | £340,412,000 | £252,988,000 | |
| Net profit | £259,040,000 | £189,312,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £842,947,000 | £726,540,000 | |
| Net assets | £763,853,000 | £646,682,000 | |
| Equity | £763,853,000 | £646,682,000 | |
| Average employees | 701 | 713 | |
| Wages | £58,360,000 | £62,903,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 48.7% | 36.0% | |
| Net margin | 39.1% | 28.6% | |
| Return on capital employed | 38.2% | 32.7% | |
| Current ratio | 4.28x | 2.05x | |
| Interest cover | 301.54x | 168.35x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Constantin
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have a reasonable expectation that the company has resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis of accounting in preparing the annual financial statements.”
Group structure
- IPSEN BIOPHARM LIMITED · parent
- Ipsen Pty Ltd 100%
- Pothold Limited 100%
- Specwood Limited 100%
Significant events
- “Net Sales of Onivyde® in Europe and Asia during FY 2024 exceeded the sales thresholds triggering a $50 million milestone payment as per the Assignment, Sublicense, and Collaboration Agreement with PharmaEngine Inc. This was executed on 3rd March 2025.”
- “Ipsen was again recognised with GPTW certification in September 2024.”
- “A new UK Global Hub was created in Paddington, London in March 2024, bringing together office-based Milton Park and Slough colleagues.”
- “The board of directors reviewed the impact of reciprocal tariffs imposed by the US on the exports of goods and services to the US applicable from 2 April 2025 at a baseline of 10%.”
- “Ipsen Biopharm is manufacturing Dysport for sale on both the Ukrainian and Russian markets.”
- “In 2024, CO2 emissions for Scope 1 and Scope 2 (market-based) decreased by 9% vs 2019, during the same period the production has increased by 70% (£661 million sales vs. £389 million in 2019).”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 52 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MILLAR-KELLY, Lynne Elizabeth Duncan | Secretary | 2022-03-16 | — | — |
| BREND, Jeannette | Director | 2022-11-01 | Nov 1971 | British |
| CHADDOCK, John Andrew, Dr | Director | 2016-11-18 | Aug 1968 | British |
| MILLAR-KELLY, Lynne Elizabeth Duncan | Director | 2022-03-16 | Aug 1983 | British |
| PARSONS, Ioana | Director | 2024-03-08 | Feb 1979 | Romanian,British |
| VISCIGLIO, Alexandre | Director | 2021-05-28 | Jan 1979 | French |
Show 52 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOOTH, Edward Andrew | Secretary | 2013-07-01 | 2015-04-30 |
| BUSBY, Robyn Elizabeth | Secretary | 2018-05-31 | 2018-10-11 |
| DAVIS, John Charles | Secretary | — | 2013-06-30 |
| LAMB, Catherine | Secretary | 2018-10-11 | 2020-10-15 |
| MILLAR, Lynne | Secretary | 2020-10-15 | 2021-05-28 |
| PULLEN, Jane Elizabeth | Secretary | 2015-04-30 | 2018-05-31 |
| TOMKINSON, Re-Natta | Secretary | 2021-05-28 | 2022-03-16 |
| ALI, Asad Mohsin | Director | 2018-10-15 | 2022-03-16 |
| ALLSOP, Judith Mary | Director | 2015-03-31 | 2018-05-01 |
| BARNSLEY, Jonathan Henry | Director | 2014-08-27 | 2017-12-22 |
| BEAUFOUR, Albert Henri, Dr | Director | 1994-12-12 | 2000-01-28 |
| BEAUFOUR, Philippe Henri | Director | 1994-12-12 | 1998-12-17 |
| BOOTH, Edward Andrew | Director | 2013-07-01 | 2016-02-11 |
| BOYNE, Isobel Louise | Director | 2018-03-27 | 2021-05-28 |
| BURKE, John Vernon | Director | — | 1993-07-15 |
| BUSBY, Robyn Elizabeth | Director | 2016-11-18 | 2018-10-11 |
| CANAL, Christophe Alain Edmond Georges | Director | 2007-08-01 | 2008-12-12 |
| CHILVER, Amos Henry, Lord | Director | 1995-02-01 | 2001-10-24 |
| CHILVER, Amos Henry, Lord | Director | — | 1994-11-30 |
| DAFOUR, Gabriel | Director | 1994-12-12 | 2001-12-26 |
| DAVIS, John Charles | Director | 2001-11-15 | 2013-06-30 |
| DAVIS, Nicholas Edward | Director | 2017-12-08 | 2020-11-30 |
| DE LA TOUR, Christian | Director | 2001-11-15 | 2014-11-25 |
| DRAPE, Eric | Director | 2007-07-25 | 2013-07-26 |
| FRANCOIS, Stephane | Director | 1994-12-12 | 2004-04-01 |
| GOVER, Anthony David | Director | — | 2001-12-14 |
| GROSSART, Angus Mcfarlane Mcleod, Sir | Director | 1995-02-01 | 2001-10-24 |
| GROSSART, Angus Mcfarlane Mcleod, Sir | Director | — | 1994-11-30 |
| HARSANYI, Zsolt, Doctor | Director | — | 2001-12-17 |
| HARVEY, Michael John | Director | 2004-03-03 | 2010-09-30 |
| HAYDON-BAILLIE, Wensley Grosvenor | Director | — | 1992-07-03 |
| HICKLING, Matthew Francis, Dr | Director | 2016-03-01 | 2018-05-02 |
| HILL, Steven Thomas | Director | 2007-06-27 | 2009-12-03 |
| JOCHEM, Olivier | Director | 2015-03-31 | 2016-02-10 |
| KRIEGER, Matthias, Dr | Director | 2021-04-27 | 2022-07-11 |
| LAMB, Catherine Anne | Director | 2018-10-15 | 2020-10-30 |
| LAUNAY, Nicole Bernadette | Director | 2015-03-31 | 2018-05-02 |
| MCDOWALL, Ewan John | Director | 2016-11-18 | 2018-10-11 |
| MILLAR, Lynne | Director | 2020-10-15 | 2021-05-28 |
| MURPHY, Aidan Gerard, Dr | Director | 2015-03-31 | 2018-01-01 |
| OLIVER, Guy Edward | Director | 2022-04-25 | 2024-03-08 |
| PADGETT, Robert Alan | Director | 1993-08-18 | 1994-11-30 |
| PULLEN, Jane Elizabeth | Director | 2016-02-11 | 2017-06-13 |
| PURTON, Peter John | Director | 1993-08-18 | 1994-11-30 |
| SAVAGE, John William | Director | 2001-11-15 | 2004-06-23 |
| SEMERJIAN, Harout | Director | 2017-12-08 | 2018-05-02 |
| SHEDDEN, William Ian Hamilton, Doctor | Director | 1994-12-12 | 1998-01-01 |
| STOKES, Alistair Michael, Dr | Director | 1992-05-27 | 2009-12-31 |
| STRATTON, Anthony Hugh | Director | 2017-06-13 | 2018-03-28 |
| TOMKINSON, Re-Natta Dominica | Director | 2021-05-28 | 2022-03-16 |
| WHITEHOUSE, Peter George | Director | 2005-10-07 | 2007-04-04 |
| WILSON, Peter Charles | Director | 2001-11-15 | 2007-06-25 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ipsen Developments Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 274 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-04-11 RESOLUTIONS Resolution
- 2023-04-11 MA Memorandum articles
- 2023-03-30 CC04 Statement of companys objects
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-06 | CH01 | officers | Change person director company with change date | |
| 2026-03-02 | CH01 | officers | Change person director company with change date | |
| 2026-03-02 | CH01 | officers | Change person director company with change date | |
| 2025-10-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-05-13 | AA | accounts | Accounts with accounts type full | |
| 2024-10-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-01 | CH01 | officers | Change person director company with change date | |
| 2024-07-30 | AA | accounts | Accounts with accounts type full | |
| 2024-03-08 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-08 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-04 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-10-05 | AA | accounts | Accounts with accounts type full | |
| 2023-10-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-11 | RESOLUTIONS | resolution | Resolution | |
| 2023-04-11 | MA | incorporation | Memorandum articles | |
| 2023-03-30 | CC04 | change-of-constitution | Statement of companys objects | |
| 2022-11-02 | AP01 | officers | Appoint person director company with name date | |
| 2022-10-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-29 | AA | accounts | Accounts with accounts type full | |
| 2022-07-13 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-0.1%
£661,765,000 £660,832,000
-
Cash
—
Not reported
-
Net assets
-15.3%
£763,853,000 £646,682,000
-
Employees
+1.7%
701 713
-
Operating profit
-26.3%
£322,346,000 £237,706,000
-
Profit before tax
-25.7%
£340,412,000 £252,988,000
-
Wages
+7.8%
£58,360,000 £62,903,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers